Cargando…

Constitutive Expression of the Immunosuppressive Tryptophan Dioxygenase TDO2 in Glioblastoma Is Driven by the Transcription Factor C/EBPβ

Catabolism of the essential amino acid tryptophan is a key metabolic pathway contributing to the immunosuppressive tumor microenvironment and therefore a viable drug target for cancer immunotherapy. In addition to the rate-limiting enzyme indoleamine-2,3-dioxygenase-1 (IDO1), tryptophan catabolism v...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kudo, Takumi, Prentzell, Mirja T., Mohapatra, Soumya R., Sahm, Felix, Zhao, Zhongliang, Grummt, Ingrid, Wick, Wolfgang, Opitz, Christiane A., Platten, Michael, Green, Edward W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7239998/ https://www.ncbi.nlm.nih.gov/pubmed/32477324 http://dx.doi.org/10.3389/fimmu.2020.00657

Ejemplares similares

Tryptophan-2,3-Dioxygenase (TDO) deficiency is associated with subclinical neuroprotection in a mouse model of multiple sclerosis
por: Lanz, Tobias V., et al.
Publicado: (2017)

The Indoleamine-2,3-Dioxygenase (IDO) Inhibitor 1-Methyl-D-tryptophan Upregulates IDO1 in Human Cancer Cells
por: Opitz, Christiane A., et al.
Publicado: (2011)

Hypoxia Inducible Factor 1α Inhibits the Expression of Immunosuppressive Tryptophan-2,3-Dioxygenase in Glioblastoma
por: Mohapatra, Soumya R., et al.
Publicado: (2019)

Comprehensive behavioral analysis of tryptophan 2,3‐dioxygenase (Tdo2) knockout mice
por: Hattori, Satoko, et al.
Publicado: (2018)

Preclinical assessment of a novel small molecule inhibitor of tryptophan 2,3-dioxygenase 2 (TDO2)
por: Crosignani, Stefano, et al.
Publicado: (2014)

Tryptophan: A Rheostat of Cancer Immune Escape Mediated by Immunosuppressive Enzymes IDO1 and TDO
por: Kim, Minah, et al.
Publicado: (2021)

Cancer Immunotherapy by Targeting IDO1/TDO and Their Downstream Effectors
por: Platten, Michael, et al.
Publicado: (2015)

Discovery and Characterisation of Dual Inhibitors of Tryptophan 2,3-Dioxygenase (TDO2) and Indoleamine 2,3-Dioxygenase 1 (IDO1) Using Virtual Screening
por: Sari, Suat, et al.
Publicado: (2019)

The therapeutic potential of targeting tryptophan catabolism in cancer
por: Opitz, Christiane A., et al.
Publicado: (2019)

The complex biology of aryl hydrocarbon receptor activation in cancer and beyond
por: Opitz, Christiane A., et al.
Publicado: (2023)

Hypoxia Routes Tryptophan Homeostasis Towards Increased Tryptamine Production
por: Mohapatra, Soumya R., et al.
Publicado: (2021)

Evaluation of Novel Inhibitors of Tryptophan Dioxygenases for Enzyme and Species Selectivity Using Engineered Tumour Cell Lines Expressing Either Murine or Human IDO1 or TDO2
por: Tijono, Sofian M, et al.
Publicado: (2022)

Organ Correlation with Tryptophan Metabolism Obtained by Analyses of TDO-KO and QPRT-KO Mice
por: Shibata, Katsumi, et al.
Publicado: (2016)

Tryptophan metabolism is inversely regulated in the tumor and blood of patients with glioblastoma
por: Panitz, Verena, et al.
Publicado: (2021)

Editorial: Targeting Indoleamine 2,3-dioxygenases and Tryptophan Dioxygenase for Cancer Immunotherapy
por: Brochez, Lieve, et al.
Publicado: (2021)

Targeting Indoleamine Dioxygenase and Tryptophan Dioxygenase in Cancer Immunotherapy: Clinical Progress and Challenges
por: Peng, Xuerun, et al.
Publicado: (2022)

Endothelial Indoleamine-2,3-Dioxygenase-1 is not Critically Involved in Regulating Antitumor Immunity in the Central Nervous System
por: Abu Hejleh, AP, et al.
Publicado: (2023)

Exploring the mechanism of tryptophan 2,3-dioxygenase
por: Thackray, Sarah J., et al.
Publicado: (2008)

Constitutive TDO2 expression promotes liver cancer progression by an autocrine IL-6 signaling pathway
por: Wu, Zhengzhong, et al.
Publicado: (2021)

Constitutive IDO expression in human cancer is sustained by an autocrine signaling loop involving IL-6, STAT3 and the AHR
por: Litzenburger, Ulrike M., et al.
Publicado: (2014)

Upregulation of tryptophanyl-tRNA synthethase adapts human cancer cells to nutritional stress caused by tryptophan degradation
por: Adam, Isabell, et al.
Publicado: (2018)

Tryptophan-Restriction Diets Help to Maintain L-Tryptophan Homeostasis in Tryptophan 2,3-Dioxygenase Knockout Mice
por: Maeta, Akihiro, et al.
Publicado: (2013)

TDO Promotes Hepatocellular Carcinoma Progression
por: Li, Shanbao, et al.
Publicado: (2020)

The TSC Complex-mTORC1 Axis: From Lysosomes to Stress Granules and Back
por: Rehbein, Ulrike, et al.
Publicado: (2021)

Indoleamine dioxygenase and tryptophan dioxygenase activities are regulated through control of cell heme allocation by nitric oxide
por: Biswas, Pranjal, et al.
Publicado: (2023)

Negative Impact of Hypoxia on Tryptophan 2,3-Dioxygenase Function
por: Elbers, Frank, et al.
Publicado: (2016)

Expression of Tryptophan 2,3-Dioxygenase in Metastatic Uveal Melanoma
por: Terai, Mizue, et al.
Publicado: (2020)

Tryptophan metabolism induced by TDO2 promotes prostatic cancer chemotherapy resistance in a AhR/c-Myc dependent manner
por: Li, Fan, et al.
Publicado: (2021)

Influence of Tryptophan Contained in 1-Methyl-Tryptophan on Antimicrobial and Immunoregulatory Functions of Indoleamine 2,3-Dioxygenase
por: Schmidt, Silvia K., et al.
Publicado: (2012)

A narrative review of the roles of indoleamine 2,3-dioxygenase and tryptophan-2,3-dioxygenase in liver diseases
por: Zhou, Qihui, et al.
Publicado: (2021)

Kynurenine Is the Main Metabolite of Tryptophan Degradation by Tryptophan 2,3-Dioxygenase in HepG2 Tumor Cells
por: Oweira, Hani, et al.
Publicado: (2022)

Identification and Characterization of a Novel Dual Inhibitor of Indoleamine 2,3-dioxygenase 1 and Tryptophan 2,3-dioxygenase
por: Yoshioka, Saeko, et al.
Publicado: (2022)

Indoximod opposes the immunosuppressive effects mediated by IDO and TDO via modulation of AhR function and activation of mTORC1
por: Brincks, Erik L., et al.
Publicado: (2020)

Dietary tryptophan links encephalogenicity of autoreactive T cells with gut microbial ecology
por: Sonner, Jana K., et al.
Publicado: (2019)

On the Non-Redundant Roles of TDO2 and IDO1
por: Puccetti, Paolo
Publicado: (2014)

Pharmacological validation of TDO as a target for Parkinson’s disease
por: Perez‐Pardo, Paula, et al.
Publicado: (2021)

Modulation of Tryptophan Metabolism, Pomotion of Neurogenesis and Alteration of Anxiety-Related Behavior in Tryptophan 2,3-Dioxygenase-Deficient Mice
por: Funakoshi, Hiroshi, et al.
Publicado: (2011)

Expression Pattern and Clinicopathological Relevance of the Indoleamine 2,3-Dioxygenase 1/Tryptophan 2,3-Dioxygenase Protein in Colorectal Cancer
por: Chen, I-Chien, et al.
Publicado: (2016)

Different Mechanisms of Catalytic Complex Formation in Two L-Tryptophan Processing Dioxygenases
por: Nienhaus, Karin, et al.
Publicado: (2018)

The Plasma [Kynurenine]/[Tryptophan] Ratio and Indoleamine 2,3-Dioxygenase: Time for Appraisal
por: Badawy, Abdulla A-B, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_334ali0gsge5s1kspc3vsh04pj